Welcome To Campus Sanofi KSA
- Article
- Campus Sanofi
- May 14, 2025
Access all the content and events you need to continue growing as a health professional.
Log InScientific News
GvHD in Focus Risk Factors and Symptoms
This educational video highlights chronic Graft‑versus‑Host Disease (cGvHD), a long‑term complication following allogeneic stem cell transplantation. It outlines key risk factors for cGVHD and demonstrates common clinical manifestations affecting skin, eyes, mouth, lungs, joints, GI tract, scalp, liver, and Fascia. The video emphasizes early recognition to support timely management and improved long‑term outcomes.
Learn more
Real-World Effectiveness of Nirsevimab: Evidence from the NIRSE-GAL Study
The NIRSE-GAL study is an ongoing population-based, prospective, longitudinal study conducted in Galicia, Spain. It includes infants eligible to receive nirsevimab and evaluates its impact on RSV-related outcomes in both inpatient and outpatient healthcare settings.
Learn more
.png)
